Roberta Cavalli è Professore Ordinario di Tecnologia Farmaceutica, presso il Dipartimento di Scienza e Tecnologia del Farmaco - Università di Torino. E' titolare dei seguenti corsi di insegnamento: Tecnologia, Socioeconomia e Legislazione Farmaceutiche; Formulazione e fabbricazione industriale di medicinali biotecnologici; Sviluppo di formulazioni topiche e dermatologiche; Advanced Drug Delivery Systems. E' Presidente del Corso di Kaurea MAgistrale in Chimica e Tecnologia Farmaceutiche, Coordinatrice Dottorato in Scienze Farmaceutiche e Biomolecolari. Roberta Cavalli ha un'esperienza pluriennale nella progettazione e nello sviluppo di sistemi di veicolazione di farmaci basati sia su approcci convenzionali sia nanotecnologici, nonchè della loro caratterizzazione in vitro e in vivo e sui modelli animali, evidenziata da numerose pubblicazioni internazioni, comunicazioni a congressi e brevetti. Co-autore di oltre 230 pubblicazioni su riviste internazionali e co-inventore di oltre 30 brevetti. Numero di citazioni superiore a 9900, H index 57

 Prof. Ida Genta is full professor of Pharmaceutical Technology (SSD CHEM-08/A) in the Department of Drug Sciences at the University of Pavia. She is the coordinator of the II level Master’s degree in Pharmacy. Since 2015, Delegate Councillor of the Department of Pharmaceutical Sciences, and since 2023, VicePresident of the Interdepartmental Research Center on Advanced Materials and Devices (MADE).

Her main research line deals with tailored formulations of targeted smart nanocarriers (antibody-conjugated and/or specific biopolymers) for the tunable and selective delivery of synthetic drugs and macromolecules (i.e. proteins, RNAs, mDNAs) as well as diagnostics/contrast agents. Great expertise on developing GMP-oriented microfluidics-based techniques and apparatus for the manufacturing of lipidic and polymeric nanocarriers. She is deeply involved in designing and developing of 2D/3D scaffolds for tissue regeneration (bone, cartilage, soft tissues) by electrospinning and 3D printing technologies and combining biocompatible synthetic/natural polymers and/or small entities (i.e., peptides, newly synthetized peptides and peptidomimetics).

 Stefano Giovagnoli è laureato in chimica presso Univ. Perugia. Dopo un periodo nel settore R&D presso GSK (Ware, UK), ha conseguito il dottorato in Chimica e Tecnologia del Farmaco presso Univ. Perugia spendendo un periodo di studio e ricerca presso Univ. Kentucky, Lexington (KE, USA), nei laboratori del Prof. Patrick P. DeLuca. Dopo un periodo di PostDoc presso la School of Pharmacy di Univ. Kentucky, ha assunto la posizione di ricercatore presso il Dipartimento di Scienze Farmaceutiche dell’Univ. Perugia dove è attualmente Professore Associato. I principali interessi di ricerca includono strategie per la veicolazione di proteine terapeutiche, polveri respirabili per il trattamento di patologie polmonari, nanoparticelle organiche e inorganiche per il rilascio mirato di farmaci. Il Prof. Giovagnoli serve come Editor e Board per diverse riviste internazionali. E' membro AAPS, AITUN, SCI, Italian CRS Chapter, ADRITELF, The Aerosol Society

Angela Assunta Lopedota is Associate Professor of Pharmaceutical Technology and Regulatory Affairs at the University of Bari Aldo Moro.Academic Experience: Contract Professor, University of Calabria (1998–2000) -Post-doctoral Fellow in Pharmaceutical Chemistry, University of Bari (2001–2002) - Researcher in Pharmaceutical Technology, University of Bari (since 2002). Visiting Researcher, Goethe University, Frankfurt (six months 2003) - Associate Professor, University of Bari Aldo Moro (since 2015). National Scientific Qualification as Full Professor (2023). Research Achievements: 120 publications in peer-reviewed journals, h-index 36, 3239 citations (Scopus Source), national and international patents, presentations at international and national conferences. Research Focus: Innovative formulations for age-related conditions, especially paediatric patients.  Microparticles via prilling/vibration and spray drying for human, veterinary, and dietary supplement applications.  Microfluidics and 3D printing for advanced and personalized medicine. Modified cyclodextrins for enhanced drug delivery. Teaching Extensive experience in Pharmaceutical Technology (CHEM 08/A) at undergraduate and postgraduate levels, at the University of Bari Aldo Moro and the Catholic University “Our Lady of Good Counsel” (Tirana, Albania).

Full professor of Pharmaceutical Technology and Regulatory aspects of drug products at the Dept. of Drug Sciences, University of Pavia, I coordinate the EMJMD NANOMED. In my career, I was associate professor at the University of Catania and postdoc at the College of Pharmacy, University of Kentucky, USA. My scientific research focuses on drug delivery and tissue engineering, encompassing design and development, through emerging manufacturing techniques such as electrospinning, microfluidics and 3Dprinting, of drug loaded liposomes, polymer nanoparticles and biodegradable polymer scaffolds as platform for soft tissue regeneration (i.e. vascular grafts and biomimetic esophagus), and their physical-chemical characterization. I collaborate with Italian and foreign academics, companies, and hospitals. I am currently involved in PNNR PE13 INF-ACT (Italian Ministry of University) and Immunohub (Italian Health Dept) projects for the delivery of anti-infective and immunomodulatory drugs. I am member of the editorial boards of international peer reviewed Journals, and scientific associations CRS, AAPS. Author of 201 publications in International peer-reviewed journals, 6386 citations, 43 h-index (Scopus 28/08/2025) 2 patents.

Paolo Decuzzi is a Senior Scientist and Professor of Biomedical Engineering at the Italian Institute of Technology in Genoa – Italy where, in July 2015, established the Laboratory of Nanotechnology for Precision Medicine returning in Europe after 10 years of activities conducted in different Clinical Research Institutions in Houston (Texas – USA). Decuzzi is a board member of multiple scientific associations, institutions, and advisory panels, including the Controlled Release Society, IIT, ERC, and the Academic Biotech Accelerator SPARK at Stanford. His multidisciplinary research focuses on the rational design of nanoconstructs and implantable devices for the treatment and imaging of various diseases, including cancer, cardiovascular, metabolic, and neurological disorders. In this context, Decuzzi has published 200+ scientific manuscripts and generated 10+ patents. His activities have been funded by multiple US and EU organizations and private corporations totaling over $15 million.

Pietro Matricardi is a Full Professor at Tor Vergata University of Rome, Italy. His research focuses on developing new materials based on polysaccharides for drug delivery and tissue engineering applications. He conducts studies on macro and micro hydrogel systems, tablets, microspheres, and self-assembling polysaccharide nanohydrogels. He pays particular attention to Interpenetrating Polymer Networks and nanohydrogels composed of polysaccharides or polysaccharide/synthetic polymer systems. Currently, he teaches "Pharmaceutical Technology and Legislation" at Tor Vergata University. Previously, he taught "Pharmaceutical Technology and Legislation," "Nanotechnology," and "Polymers for Pharmaceuticals" at Sapienza University, where he instructed students in the Chemistry and Pharmaceutical Technology program. Pietro Matricardi earned his M.Sc. (Laurea) in Chemistry in 1989 and his Ph.D. in 1993 from Sapienza University of Rome. In 1993, he joined the Lepetit Group at their Anagni site. In 1994, he transitioned to the risk assessment unit of INAIL. In 2004, he became an Associate Professor in the Drug Chemistry and Technologies Department at Sapienza University of Rome. In 2019 and 2021, he was appointed Associate Professor and Full Professor. He finally joined the Department of Biology at Tor Vergata University of Rome in 2025. Pietro Matricardi serves as a guest editor and is a member of the editorial board for several journals in the fields of drug delivery, pharmaceutics, and carbohydrate polymers. He has published over 115 papers in international peer-reviewed journals and holds five patents. Additionally, he has participated as a lecturer at numerous conferences, written a book, and contributed to various book chapters.

Full Professor of Pharmaceutical Technology and Legislation at the Department of Drug and Health Sciences of the University of Catania, where he has served as Director since 2018. Since the same year, he has also been a member of the Academic Senate of the University of Catania. He is currently a member of the Board of Arbitrators (Collegio dei Probiviri) of the CRS Italy Chapter. His teaching activity primarily focuses on Pharmaceutical Technology and Health and Environmental Legislation. His scientific research is centered on selected areas of innovative pharmaceutical technology, with particular emphasis on the development and characterization of polymeric and lipid-based micro- and nanosystems for drug delivery and targeting to the eye, brain, and colon. He serves as Editor or member of the Editorial Board of several international journals in the field, has edited multiple Special Issues, and is the author of several volumes on drug delivery.